These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2736295)

  • 1. [Effect of the new anti-arrhythmia preparation Bonnecor on the hemodynamics and activity of the ischemic heart].
    Tolmacheva EA; Chichkanov GG; Matsievskiĭ DD
    Biull Eksp Biol Med; 1989 May; 107(5):588-90. PubMed ID: 2736295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
    Chichkanov GG; Tolmacheva EA; Lyskovtsev VV; Grigor'eva EK; Matsievskiĭ DD
    Farmakol Toksikol; 1990; 53(3):38-40. PubMed ID: 2387378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative].
    Berdiaev SIu; Marko R; Kelemen K; Darinskiĭ NV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):16-9. PubMed ID: 3531669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antifibrillatory properties of bonnecor].
    Grigor'eva EK; Gorbunova VV
    Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical study of bonnecor in the treatment of heart rhythm disorders in patients with ischemic heart disease].
    Gorshkov VA; Solodukhina IS; Kesarev GV; Kurakina TI; Solov'eva FV
    Sov Med; 1991; (7):45-7. PubMed ID: 1948344
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of ecdysterone on experimental arrhythmias and changes in the hemodynamics and myocardial contractility induced by coronary artery occlusion].
    Kurmukov AG; Ermishina OA
    Farmakol Toksikol; 1991; 54(1):27-9. PubMed ID: 1860493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anti-arrhythmia properties of bonnecor metabolites].
    Grigor'eva EK; Poppe H; Tolmacheva EA; Krasnykh LM
    Farmakol Toksikol; 1990; 53(3):48-50. PubMed ID: 2387382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of bonnecor in ischemic heart disease].
    Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
    Sov Med; 1990; (6):72-4. PubMed ID: 2396129
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative anti-arrhythmia activity of befol, lidocaine, and bonnecor].
    Galenko-Iaroshevskiĭ PA; Khankoeva AI; Uvarov AV; Reznikov AIu; Galygo DS; Bartashevich VV
    Biull Eksp Biol Med; 1996 Dec; 122(12):665-8. PubMed ID: 9280469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
    Senova ZP; Lyskovtsev VV; Grigor'eva EK; Gorbunova VV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the effectiveness of Bonnecor and ethacizine in various disorders of cardiac rhythm].
    Tatarchenko IP; Ermolaeva NN; Oleĭnikov VE; Perevarin AV; Rakhmatullov FK
    Klin Med (Mosk); 1991 Aug; 69(8):60-2. PubMed ID: 1724273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effect of ethmozine and its diethylamine analog ethacizin on central hemodynamics in patients with various functional states of the myocardium].
    Ageev FT; Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):113-5. PubMed ID: 3890894
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of bonnecor on blood coagulability and thrombocyte aggregation in transient myocardial ischemia].
    Denisova SV; Sapozhkov AV
    Eksp Klin Farmakol; 1992; 55(6):29-31. PubMed ID: 1305870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug].
    Assmann I; Kassel P; von Knorre G
    Z Gesamte Inn Med; 1990 Dec; 45(23):703-8. PubMed ID: 1714669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of anti-arrhythmia agents in ischemia and hyperoxia].
    Kedrov SI; Reznikov KM; Leonov AN
    Farmakol Toksikol; 1988; 51(1):41-4. PubMed ID: 3360106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.